Global Active Pharmaceutical Ingredients (API) Market worth USD 154.88 billion in 2016 and expected to reach USD 224.63 billion by 2022, at a CAGR of 6.4% from 2016 to 2022.

The global active pharmaceutical ingredients (API) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the active pharmaceutical ingredients (API) market.

KEY BENEFITS OF THE REPORT:
Thorough understanding of the dynamics influencing the various segments of this market
Detailed analysis of the regulatory environment impacting the growth of this market
Valuable insights into the key technological and market trends impacting this market
KEY PREMIUM INDUSTRY INSIGHTS:
The advancements in biologics, increasing local manufacture, the rise in the aging population, and the increasing number of chronic disease are the major drivers for the active pharmaceutical ingredients (API) market.
The increasing awareness towards generic drugs, government initiatives, and better market penetration are some of the other factors that will boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.
However, the high cost of manufacturing, the regulatory norms, and financial instability are the major restraints for the global active pharmaceutical ingredients (API) market.
MARKET SEGMENTATION:
This report analyzes the active pharmaceutical ingredients (API) market by the following segments:

Active Pharmaceutical Ingredient (API) Market, by Manufacturer
Captive
Merchant
Active Pharmaceutical Ingredient (API) Market, by Synthesis
Synthetic
Biological
Active Pharmaceutical Ingredient (API) Market, by Drug Type
Generic
Branded
Active Pharmaceutical Ingredient (API) Market, by Classification
HPAPI
Others
Active Pharmaceutical Ingredient (API) Market, by Therapeutic Area
Cardiovascular Disorders
Metabolic Disorders
CNS
Oncology
Musculoskeletal Diseases
NSAIDs
Others
KEY MARKET PLAYERS:
Key players in the active pharmaceutical ingredients (API) market include:

Teva Pharmaceutical Industries, Ltd.
Sun Pharmaceutical Industries, Ltd.
Dr.Reddy's Laboratories
Aurobindo Pharma Ltd.
Mylan N.V.
Novartis AG
Cambrex Corporation
Boehringer Ingelheim GmbH
Pfizer, Inc.
Lonza Group